Show simple item record

dc.contributor.authorFresneau, B
dc.contributor.authorHackshaw, A
dc.contributor.authorHawkins, DS
dc.contributor.authorPaulussen, M
dc.contributor.authorAnderson, JR
dc.contributor.authorJudson, I
dc.contributor.authorLitiere, S
dc.contributor.authorDirksen, U
dc.contributor.authorLewis, I
dc.contributor.authorvan den Berg, H
dc.contributor.authorGaspar, N
dc.contributor.authorGelderblom, H
dc.contributor.authorWhelan, J
dc.contributor.authorBoddy, AV
dc.contributor.authorWheatley, K
dc.contributor.authorPignon, JP
dc.contributor.authorDe Vathaire, F
dc.contributor.authorLe Deley, MC
dc.contributor.authorLe Teuff, G
dc.date.accessioned2018-02-19T16:30:04Z
dc.date.issued2017-08
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403320600032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifierARTN e26457
dc.identifier.citationPEDIATRIC BLOOD & CANCER, 2017, 64 (8)
dc.identifier.issn1545-5009
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1321
dc.identifier.eissn1545-5017
dc.identifier.doi10.1002/pbc.26457
dc.languageeng
dc.language.isoeng
dc.subjectacute toxicity
dc.subjectalkylating agent
dc.subjectcyclophosphamide
dc.subjectefficacy
dc.subjectifosfamide
dc.subjectindividual patient data
dc.subjectmeta-analysis
dc.subjectsarcoma
dc.subjectsystematic review
dc.subjecttreatment-by sex interaction
dc.titleInvestigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)
dc.typeJournal Article
rioxxterms.versionofrecord10.1002/pbc.26457
rioxxterms.licenseref.startdate2017-08
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfPEDIATRIC BLOOD & CANCER
pubs.issue8
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume64
pubs.embargo.termsNot known
icr.researchteamSarcoma Clinical Trialsen_US
dc.contributor.icrauthorJudson, Ianen
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record